Get the Stockscreener App
13.80
3.63%
-0.52
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Natures Sunshine Products Inc stock is traded at $13.80, with a volume of 63,627.
It is down -3.63% in the last 24 hours and up +17.35% over the past month.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
See More
Previous Close:
$14.32
Open:
$14.24
24h Volume:
63,627
Relative Volume:
1.31
Market Cap:
$230.86M
Revenue:
$445.10M
Net Income/Loss:
$16.98M
P/E Ratio:
15.68
EPS:
0.88
Net Cash Flow:
$12.69M
1W Performance:
+10.49%
1M Performance:
+17.35%
6M Performance:
-7.38%
1Y Performance:
-11.65%
1-Day Range:
$13.52
$14.35
1-Week Range:
$12.24
$14.35
52-Week Range:
$10.80
$18.06
Natures Sunshine Products Inc Stock (NATR) Company Profile
Name
Natures Sunshine Products Inc
Sector
Industry
Phone
(801) 341-7900
Address
2901 WEST BLUEGRASS BLVD., LEHI
Compare NATR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NATR
Natures Sunshine Products Inc
|
13.80 | 230.86M | 445.10M | 16.98M | 12.69M | 0.88 |
|
KHC
Kraft Heinz Co
|
28.07 | 33.90B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
54.50 | 30.35B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.48 | 28.75B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
76.07 | 20.39B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.21 | 16.12B | 11.92B | 805.04M | 1.01B | 1.46 |
Natures Sunshine Products Inc Stock (NATR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-25 | Resumed | DA Davidson | Buy |
| Sep-13-24 | Initiated | Canaccord Genuity | Buy |
| Oct-15-21 | Initiated | DA Davidson | Buy |
| Apr-09-15 | Initiated | Imperial Capital | In-line |
| Jun-02-14 | Initiated | Singular Research | Buy |
| Mar-08-13 | Reiterated | Imperial Capital | In-line |
View All
Natures Sunshine Products Inc Stock (NATR) Latest News
First Trust Advisors LP Has $564,000 Stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Dimensional Fund Advisors LP Increases Holdings in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Nature's Sunshine Products, Inc. Just Recorded A 52% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo
Barclays PLC Buys 2,091 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Nature's Sunshine (NATR) Receives Buy Rating with Revised Price Target | NATR Stock News - GuruFocus
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q1 2025 Earnings Call Transcript - Insider Monkey
Natures Sunshine Products Inc (NATR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Natures Sunshine Products Inc (NATR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - GuruFocus
Natures Sunshine Products Inc (NATR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Natures Sunshine Products Inc (NATR) Q1 2025 Earnings Call Highl - GuruFocus
Nature’s Sunshine Reports Strong Q1 2025 Results - TipRanks
Nature's Sunshine: Q1 Earnings Snapshot - CTPost
Earnings call transcript: Nature’s Sunshine beats Q1 2025 expectations - Investing.com
Nature's Sunshine (NASDAQ:NATR) Beats Q1 Sales Targets - Yahoo Finance
NATURES SUNSHINE PRODUCTS INC SEC 10-Q Report - TradingView
Nature’s Sunshine Q1 2025 slides: profit doubles on modest revenue growth - Investing.com
Nature's Sunshine Reports Strong First Quarter 2025 Results - GlobeNewswire
Nature's Sunshine Products: Near-Term Weakness But Attractive Entry Point For Long-Term Investors - Seeking Alpha
Nature's Sunshine Products Names Board Chairman - marketscreener.com
Natures Sunshine Products Inc (NATR) Q1 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
Nature's Sunshine (NATR) Appoints Heidi Wissmiller as New Chairman | NATR Stock News - GuruFocus
Nature’s Sunshine Appoints Heidi Wissmiller as Chairman of the Board - GlobeNewswire
Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board - The Manila Times
Nature's Sunshine Appoints Heidi Wissmiller As Chairman - marketscreener.com
Nature's Sunshine Taps $1B Growth Leader Heidi Wissmiller as Board Chairman: Digital Innovation Push - Stock Titan
Nature's Sunshine (NATR) Reports Q1: Everything You Need To Know Ahead Of Earnings - FinancialContent
Invesco Ltd. Sells 3,222 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Nature’s Sunshine Products (NATR) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Nature's Sunshine Products Inc expected to post earnings of 17 cents a shareEarnings Preview - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
JPMorgan Chase & Co. Acquires 25,644 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Russell Investments Group Ltd. Acquires New Holdings in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Geode Capital Management LLC Sells 1,936 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Nature’s Sunshine Releases 2024 Impact Report - Direct Selling News
Nature's Sunshine Wins Two Stevie® Awards in the 2025 American Business Awards® - The Manila Times
Nature's Sunshine Products Recognized with Two Stevie Awards for Impact Report and Product Innovation - Nasdaq
Nature's Sunshine Wins Two Stevie® Awards in the 2025 American Business Awards® - GlobeNewswire Inc.
Nature's Sunshine Releases 2024 Impact Report Highlighting Envir - GuruFocus
Nature's Sunshine Releases 2024 Impact Report Highlighting Environmental and Sustainability Achievements | NATR Stock News - GuruFocus
Nature's Sunshine Releases 2024 Impact Report Highlighting Environmental and Sustainability Achievements - GlobeNewswire
Nature's Sunshine Products, Inc.'s (NASDAQ:NATR) CEO Might Not Expect Shareholders To Be So Generous This Year - simplywall.st
Nature's Sunshine Sets First Quarter 2025 Conference Call for Tu - GuruFocus
Nature’s Sunshine Sets First Quarter 2025 Conference Call for Tuesday, May 6, 2025, at 5:00 p.m. ET - GlobeNewswire
Nature's Sunshine Products, Inc. to Host Conference Call on May 6, 2025, to Discuss Q1 Financial Results - Nasdaq
Nature's Sunshine Sets Q1 2025 Earnings Conference Call: CEO and CFO to Present Latest Financial Results - Stock Titan
Nature’s Sunshine Products (NASDAQ:NATR) Raised to “Strong-Buy” at DA Davidson - Defense World
Arrowstreet Capital Limited Partnership Sells 12,536 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
American Century Companies Inc. Grows Stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Proficio Capital Partners LLC Acquires New Shares in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement - The Globe and Mail
Connor Clark & Lunn Investment Management Ltd. Acquires New Shares in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) - Defense World
Natures Sunshine Products Inc Stock (NATR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Natures Sunshine Products Inc Stock (NATR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 15 '24 |
Sale |
13.02 |
2,300 |
29,946 |
64,167 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 10 '24 |
Sale |
13.39 |
3,000 |
40,170 |
69,347 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 09 '24 |
Sale |
13.36 |
1,816 |
24,262 |
72,347 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 08 '24 |
Sale |
13.13 |
1,800 |
23,634 |
74,163 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 11 '24 |
Sale |
13.37 |
1,580 |
21,125 |
67,767 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 01 '24 |
Sale |
13.54 |
1,399 |
18,942 |
75,963 |
| Shanghai Fosun Pharmaceutical | 10% Owner |
Oct 14 '24 |
Sale |
13.12 |
1,300 |
17,056 |
66,467 |
| Yates Bryant J | EVP & President, Europe |
Jun 06 '24 |
Sale |
15.30 |
3,068 |
46,940 |
98,852 |
1.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):